ONE-TWENTY TWO: Trading Financial Markets
Since the year 2000, delivering a different narrative for students and fans of financial markets: stocks, options, currencies, Bitcoin, and more…
AT40 = 73.8% of stocks are trading above their respective 40-day moving averages (DMAs) – overbought day #7 AT200 = 59.7% of stocks are trading above their respective 200DMAs VIX = 9.7 Short-term Trading Call: bullish Commentary This is what a lift-off for an extended overbought rally looks like. The S&P 500 (SPY) followed its … Read more
AT40 = 71.3% of stocks are trading above their respective 40-day moving averages (DMAs) – overbought day #2 AT200 = 58.6% of stocks are trading above their respective 200DMAs VIX = 9.5 Short-term Trading Call: bullish Commentary It looks like an overbought rally is truly underway. AT40 (T2108), the percentage of stocks closing above their … Read more
I took immediate notice when Axovant Sciences (AXON) went public back in late 2015. The promise of a treatment for Alzheimer’s was a huge opportunity, and I immediately had thoughts of my grandfather who struggled with the disease for years before he passed away with a heart attack. Yet, AXON had no revenues and no … Read more
AT40 = 63.6% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 54.9% of stocks are trading above their respective 200DMAs VIX = 9.6 Short-term Trading Call: cautiously bullish Commentary The stock market stubbornly held onto its bullish positioning despite the tumble of one of its biggest stalwarts: Apple (AAPL). AAPL … Read more
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more
Morgan Stanley (MS) initiated coverage on Intercept Pharmaceuticals, Inc. (ICPT) with an underweight rating. The negativity weighed on the stock for a 7.9% loss that sent the stock below critical support at its 200-day moving average (DMA). Source: FreeStockCharts.com Morgan was VERY emphatic about its “out of consensus” call on ICPT. As reported by Investors.com: … Read more
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more
After the market closed for trading on January 29, 2015, Intercept Pharmaceuticals (ICPT) released exciting news: ICPT’s “…investigational product obeticholic acid (OCA) has received “breakthrough therapy designation” from the U.S. Food and Drug Administration (FDA) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis. This indication constitutes a population of patients with … Read more